Cargando…

Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies

Inflammation contributes to growth failure associated with inflammatory bowel diseases. Anti-TNFα therapy induces sustained remission and short-term improvements in height velocity and/or height standard deviation score (H-SDS) patients with Crohn’s disease. The purpose of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bamberger, Sarah, Martinez Vinson, Christine, Mohamed, Damir, Viala, Jérôme, Carel, Jean-Claude, Hugot, Jean-Pierre, Simon, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026336/ https://www.ncbi.nlm.nih.gov/pubmed/27636201 http://dx.doi.org/10.1371/journal.pone.0163126

Ejemplares similares

Chronic Recurrent Multifocal Osteomyelitis in Pediatric Crohn Disease, A Paradoxical Effect to Antitumor Necrosis Factor Alpha
por: Cordesse, Anne, et al.
Publicado: (2020)

Effects of introduction of an inflammatory bowel disease nurse position on healthcare use
por: Martinez-Vinson, Christine, et al.
Publicado: (2020)

Differential Diagnosis Between Perianal Crohn’s Disease and Hidradenitis Suppurativa: A Challenging Teamwork
por: Amhis, Maya, et al.
Publicado: (2021)

Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
por: Le Baut, Guillaume, et al.
Publicado: (2018)

Crohn’s Disease: Is the Cold Chain Hypothesis Still Hot?
por: Hugot, Jean-Pierre, et al.
Publicado: (2020)

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
por: Otake, Haruka, et al.
Publicado: (2022)

Network Modeling of Crohn’s Disease Incidence
por: Victor, Jean-Marc, et al.
Publicado: (2016)

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
por: Moroi, Rintaro, et al.
Publicado: (2019)

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
por: Kawalec, Paweł, et al.
Publicado: (2013)

Molecular Reclassification of Crohn’s Disease: A Cautionary Note on Population Stratification
por: Maus, Bärbel, et al.
Publicado: (2013)

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data
por: Romagnoni, Alberto, et al.
Publicado: (2019)

Genotype/Phenotype Analyses for 53 Crohn’s Disease Associated Genetic Polymorphisms
por: Jung, Camille, et al.
Publicado: (2012)

Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα)
por: Cao, Brent L, et al.
Publicado: (2018)

Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
por: Pichler, Judith, et al.
Publicado: (2020)

Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn’s disease
por: Li, Kangrong, et al.
Publicado: (2023)

Crohn's Disease and Early Exposure to Domestic Refrigeration
por: Malekzadeh, Fatemeh, et al.
Publicado: (2009)

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
por: Eder, Piotr, et al.
Publicado: (2015)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
por: Yu, Jongwook, et al.
Publicado: (2022)

Hyperthyroidism in Childhood: Causes, When and How to Treat
por: Léger, Juliane, et al.
Publicado: (2013)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
por: Zaidi, Deenaz, et al.
Publicado: (2018)

A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn’s Disease
por: Nie, Kai, et al.
Publicado: (2022)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Macrophages Inability to Mediate Adherent-Invasive E. coli Replication is Linked to Autophagy in Crohn’s Disease Patients
por: Buisson, Anthony, et al.
Publicado: (2019)

Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30
por: Montes, Lydia, et al.
Publicado: (2020)

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis
por: Zaboli, Pardis, et al.
Publicado: (2017)

Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
por: Ji, Hong, et al.
Publicado: (2002)

Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates
por: Staudacher, Alexander H, et al.
Publicado: (2018)

Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case report
por: Nathoo, Sunina, et al.
Publicado: (2016)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Comparison of mucosa-associated microbiota in Crohn’s disease patients with and without anti-tumor necrosis factor-α therapy
por: Fukushima, Shinya, et al.
Publicado: (2022)

El rincón de audición : para el aprendizaje de la lengua
por: Viala, Jean-Pierre
Publicado: (1992)

Effect of a concomitant elemental diet with maintenance anti‐tumor necrosis factor‐α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study
por: Hirai, Fumihito, et al.
Publicado: (2018)

Unusual feature of neonatal hypernatremic dehydration due to microvillus inclusion disease: a case report
por: Khalsi, Fatma, et al.
Publicado: (2018)

A 256-channel pulse height analyser
por: Berset, Jean Claude, et al.
Publicado: (1975)

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention
por: Pagnini, Cristiano, et al.
Publicado: (2021)

Stricturing Crohn’s disease-like colitis in a patient treated with belatacept
por: Bozon, Anne, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist
por: Holko, Przemysław, et al.
Publicado: (2018)

Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l7ndg72nc6s68hgd752i04608n